Week In Review: bioMérieux Acquires Majority Stake In China Diagnostics Company For $114 Million
November 10, 2018 at 16:08 PM EST
French in vitro diagnostics company, bioMérieux (Paris: BIM), acquired a majority stake in Suzhou Hybiome Biomedical Engineering for $114 million. Hybiome specializes in automated immunoassay tests.